Strong profitable growth at Sartorius Stedim Biotech

Author's Avatar
Oct 20, 2020
Article's Main Image

- Nine-months results: Sales revenue 1,379.4 million euros; underlying EBITDA1 margin climbs to 31.5 percent

- High growth across all product categories and geographies

- Management specifies financial guidance at the upper end of or slightly above the range indicated so far

PR Newswire